Vicapsys Life Sciences (Vicapsys Life Sciences) GF Score : 35/100 (As of May. 26, 2024)

View and export this data going back to . Start your Free Trial

What is Vicapsys Life Sciences GF Score?

Vicapsys Life Sciences has the GF Score of 35, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 5/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Vicapsys Life Sciences might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Vicapsys Life Sciences's GF Score

For the Biotechnology subindustry, Vicapsys Life Sciences's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vicapsys Life Sciences's GF Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vicapsys Life Sciences's GF Score distribution charts can be found below:

* The bar in red indicates where Vicapsys Life Sciences's GF Score falls into.

Vicapsys Life Sciences (OTCPK:VICP) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Vicapsys Life Sciences GF Score Related Terms

Thank you for viewing the detailed overview of Vicapsys Life Sciences's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicapsys Life Sciences (Vicapsys Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicapsys Life Sciences Inc (OTCPK:VICP) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

7778 Mcginnis Ferry Road, Suite 270, Suwanee, GA, USA, 30024

Website

https://www.vicapsys.com

Vicapsys Life Sciences Inc is a biotech company that is engaged in commercializing implantable medical products that incorporate VICAPSYN, inducing a zone of immuno-protection around devices and cells implanted in the human body. The product name VICAPSYN is the company's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field.

Executives

Moore Bobby M Jr	10 percent owner	4125 S.B. MERRION ROAD, LAKELAND FL 33810
Robert Grammen	10 percent owner	9180 GALLENA COURT, NAPLES FL 34109
Michael Yurkowski	director	1505 ELM STREET, #1504, DALLAS TX 75201
William P. Esping	10 percent owner	2828 ROUTH STREET, SUITE 500, DALLAS TX 75201
Rodger Rees	director	C/O BONDS.COM GROUP, INC., 1515 SOUTH FEDERAL HIGHWAY, SUITE 212, BOCA RATON FL 33432
Mark Feldmesser	director	641 UNIVERSITY BLVE, JUPITER FL 33458
Federico Pier	director	1004 PLUM DRIVE, IRVING TX 75063
Ryan Seddon	director, 10 percent owner	8120 BELVEDERE ROAD, SUITE 4, WEST PALM BEACH FL 33411

Vicapsys Life Sciences (Vicapsys Life Sciences) Headlines

From GuruFocus

ViCapsys Life Sciences Appoints Federico Pier as Permanent Chief Executive Officer

By ACCESSWIRE ACCESSWIRE • 04-13-2022